← Open Payments lookup

DANIEL HOLLOWAY: Open Payments

NPI 1972051522 · RIDGELAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,018 in 87 payments from 14 companies in 2025. Trend: 2023 $2,578 · 2024 $2,019 · 2025 $2,018

Food & beverage: $2,018
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$306
Axsome Therapeutics, Inc.9$295
ABBVIE INC.19$232
Collegium Pharmaceutical, Inc.13$208
Otsuka America Pharmaceutical, Inc.6$195
Takeda Pharmaceuticals U.S.A., Inc.9$157
Tris Pharma Inc8$152
Supernus Pharmaceuticals, Inc.5$143
Vanda Pharmaceuticals Inc.5$127
Corium, LLC3$70

Products named: CAPLYTA, Auvelity, REXULTI, VRAYLAR, Jornay PM, TRINTELLIX, Dyanavel XR, Qelbree.

Industry payments across MS — which companies pay providers there.